Cite
HARVARD Citation
Mentz, R. et al. (2018). Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. Journal of the American Heart Association. 7 (19), p. n/a. [Online].